Clinical trials
Placebo Effect clinical trials
Below are recruiting placebo effect clinical trials, each written for real people, not researchers. We’re tracking 758 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06691217RecruitingPhase 2
Testing an Anti-Inflammatory Drug for Heart Disease With TET2 Mutation
This study tests whether a medication that blocks inflammation (called an IL-1 beta inhibitor) can reduce blood vessel inflammation in people with both heart disease and a specific genetic change in their blood cells (TET2 mutation). It aims to see if targeting this type of inflammation can help lower heart risks.
Boston, MassachusettsAges 18 years+ - NCT07234591Recruiting
Study of an oral medication for moderate to severe plaque psoriasis
This study tests an experimental oral medication (a TYK2 inhibitor) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing psoriasis symptoms.
ShanghaiAges 18–70 - NCT07427797RecruitingPhase 3
Study of a treatment for frown lines between the eyebrows
This study tests a new medicine (IPN10200) to see how well it works and how safe it is for reducing moderate to severe frown lines between the eyebrows in adults. If you are unhappy with the appearance of these lines, this trial may help.
Birmingham, AlabamaAges 18–80 - NCT07053657Recruiting
Vitamin D for heart health in overweight teens
This study looks at whether giving vitamin D can improve heart and metabolic health in overweight or obese teens who have low vitamin D levels. It may help lower risks like high blood sugar or cholesterol.
Anqing, AnhuiAges 10–16 - NCT07537868RecruitingPhase 2
Montelukast to reduce heart damage after heart attack
This study tests whether montelukast (a medication that reduces inflammation) can limit heart damage when given immediately after a sudden heart attack. Researchers will measure inflammation markers and heart injury to see if this drug helps patients recover better.
Al MansurahAges 30–75 - NCT07747909Recruiting
Orlistat for metabolic and hormonal health in PCOS
This study tests whether the weight-loss drug orlistat can improve blood sugar, hormones, and other metabolic measures in women with polycystic ovary syndrome (PCOS). If you have PCOS and are overweight, this treatment might help with symptoms like irregular periods and excess hair growth.
Abbottābād, Khyber PakhtunkhwaAges 18–45 - NCT07173751RecruitingPhase 3
Pumitamig for advanced triple-negative breast cancer
This study tests a new drug called pumitamig for people with a type of breast cancer that is triple-negative or has very low hormone receptors and has come back or spread. It aims to see if pumitamig works better than standard treatment and how safe it is for people who cannot get PD(L)-1 immunotherapy with chemo.
Springdale, ArkansasAges 18 years+ - NCT04951635RecruitingPhase 3
Almonertinib after chemoradiation for stage III lung cancer
This Phase 3 trial tests whether almonertinib given after standard chemoradiation can help people with stage III, non-surgical lung cancer live longer and/or control the cancer. It is for tumors with specific EGFR mutations linked to sensitivity to EGFR-targeted medicines.
Ji'nan, ShandongAges 18 years+ - NCT05230758RecruitingPhase 3
Metformin trial for brain tumor survivors’ brain and behavior
This Phase 3 study tests whether metformin can improve brain function, behavior, and thinking in children and teens who were treated for certain brain tumors. You may be able to join if you meet age, time-since-treatment, language, and health/lab safety requirements.
New Lambton Heights, New South WalesAges 7–21 - NCT05935826RecruitingPhase 3
Amino acids to reduce liver fat in teens with NAFLD
This study tests whether adding amino acids can lower fat stored in the liver of teens with non-alcoholic fatty liver disease (NAFLD). It may help improve liver health by changing how much liver fat is present over the study period.
Aurora, ColoradoAges 13–18 - NCT05978206RecruitingPhase 2
Strength, muscle mass, and nutrition therapy for older adults with sarcopenia
This study tests if a combination of a medicine (nandrolone), physical therapy, and a special diet can help older adults with muscle loss (sarcopenia) improve their strength and muscle mass. It is for people age 60 to 99 who have been diagnosed with sarcopenia based on specific muscle strength and mass measurements.
Warsaw, Masovian VoivodeshipAges 60–99 - NCT06138210RecruitingPhase 1/Phase 2
GD-iExo-003 treatment for recent ischemic stroke
This trial is testing a new treatment called GD-iExo-003 for people who had an acute ischemic stroke within the past week. The treatment aims to reduce damage and improve recovery by using special cells injected into the vein.
BeijingAges 18–70 - NCT06169241RecruitingEarly Phase 1
Nitrate supplement for resistant hypertension
This trial tests whether a natural nitrate supplement (like beetroot juice) can help lower blood pressure and improve blood vessel function in people with resistant hypertension. If you have resistant hypertension and your medications have been stable for at least 30 days, you may be eligible.
Rio de JaneiroAges 18–75 - NCT06184451Recruiting
TENS with exercise for knee osteoarthritis
This study tests if adding TENS (a pain-relieving electrical stimulation) to a standard exercise program helps people with knee osteoarthritis feel better and move better.
São PauloAges 40–75 - NCT06408259RecruitingPhase 3
Comparing ozanimod and fingolimod for children with MS
This study compares two oral medications, ozanimod and fingolimod, to see which one works better and is safer for children and teenagers with relapsing-remitting MS. Both drugs help reduce MS attacks and slow down the disease.
Loma Linda, CaliforniaAges 10–17 - NCT06960564Recruiting
Hyaluronic acid injection for knee osteoarthritis
This study tests whether a hyaluronic acid injection (a natural lubricant for joints) can reduce inflammation markers in the knee for people with osteoarthritis. It may be a good option if you have moderate knee pain that hasn't improved with other treatments.
IstanbulAges 45–75 - NCT07038252Recruiting
Oral supplement effect on blood vessel health in obesity and hypertension
This trial tests whether an oral supplement made from special fats (called Specialized Pro-resolving Mediators) can help reduce blood vessel damage caused by inflammation in people with obesity and high blood pressure. If you have well-controlled high blood pressure and are obese, you may be able to join.
ParisAges 18–85 - NCT07140237RecruitingEarly Phase 1
Can oxytocin improve attention?
This study tests if taking oxytocin (or a drug that blocks it) affects how well you pay attention. It helps researchers understand the role of oxytocin in focusing the mind.
Chengdu, SichuanAges 18–35 - NCT07182500RecruitingPhase 2
Can probiotics protect your gut while traveling?
This trial tests whether taking a probiotic supplement can help keep your gut bacteria healthy during a short trip abroad. It's a good fit if you are generally healthy and planning a vacation or business trip under a week.
Huangpu, Shanghai MunicipalityAges 18–65 - NCT07187544Recruiting
Carbetocin and calcium for uterine tone during c-section
This study tests if giving carbetocin with calcium helps the uterus contract better after a planned c-section. It's for women at 37+ weeks without high risk for poor uterine tone.
Toronto, OntarioAges 18–45 - NCT07241585Recruiting
Vitamin D and light therapy for skin cancer
This trial tests whether taking vitamin D before a special light therapy (photodynamic therapy) can help your body fight nonmelanoma skin cancers like basal or squamous cell cancer. You may join if you are scheduled for surgery to remove a skin tumor.
Cleveland, OhioAges 18 years+ - NCT07338682RecruitingPhase 2
L-Arginine for memory in older adults
This trial tests if L-Arginine, a natural amino acid, can improve thinking and memory in adults over 60 with mild to moderate memory problems. You may join if you have no other brain diseases or certain health conditions.
CairoAges 60 years+ - NCT07361692Recruiting
Electric brain stimulation for complex regional pain syndrome
This trial tests if a gentle electric current applied to the scalp (called tDCS) can reduce pain in people with Complex Regional Pain Syndrome (CRPS), a chronic pain condition. It aims to see if this treatment is effective and safe for managing symptoms.
Saint-NazaireAges 18 years+ - NCT07441070Recruiting
Ashwagandha for stress and sleep in sexual and gender minorities
This study tests whether an Ashwagandha root extract supplement can help lower stress, anxiety, and improve sleep quality in adults who experience stress related to being a sexual or gender minority. You would take the supplement daily for a set period and report how you feel.
San Francisco, CaliforniaAges 18–45
Hear when a new Placebo Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo effect?
- Yes. Clin2 currently lists 758 recruiting placebo effect studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo effect trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo effect trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.